News

Pharvaris Engages Audiences with Upcoming R&D Call on HAE

Pharvaris Engages Audiences with Upcoming R&D Call on HAE

Pharvaris Announces a Virtual R&D Call on Deucrictibant

Pharvaris (Nasdaq: PHVS), a biopharmaceutical company based in Zug, Switzerland, is poised to host an informative virtual R&D call titled 'Deucrictibant: Beyond HAE Type 1/2.' This event is set to delve into pivotal topics regarding bradykinin-mediated diseases such as hereditary angioedema (HAE). The call will take place at 8:00 a.m. ET/14:00 CET.

What to Expect During the Virtual Event

This engaging session will focus on a variety of aspects concerning bradykinin-mediated angioedema, including the disease's underlying biology and its prevalence. Participants will learn about current treatment options available and the unmet needs that individuals with bradykinin-mediated angioedema continue to face.

Insights into Deucrictibant

Deucrictibant shows promise in addressing these pressing needs, functioning as a potential breakthrough for those afflicted by the disease. The presentation will also outline Pharvaris’ innovative biomarker strategy aimed at effectively identifying those with bradykinin-mediated angioedema and other related conditions.

Meet the Presenters

A distinguished group of experts will lead the discussion, including:

  • Danny M. Cohn, M.D., Ph.D., renowned in the field of Vascular Medicine from Amsterdam UMC.
  • Anne Lesage, Ph.D., Chief Early Development Officer at Pharvaris.
  • Peng Lu, M.D., Ph.D., Chief Medical Officer at Pharvaris.
  • Berndt Modig, Chief Executive Officer of Pharvaris.

How to Register

Registration for the live webcast is available on the Pharvaris website under the News and Events section. After the live presentation, attendees will have access to an archived replay of the event for at least 30 days, allowing those who missed it to catch up on this important conversation.

About Pharvaris

Pharvaris is committed to developing innovative solutions in the biopharmaceutical space, particularly focusing on treatment options for bradykinin-mediated angioedema. The company aims to replicate the efficacy of injectable treatments while maximizing patient comfort through oral therapies. Currently, Pharvaris is conducting Phase 3 studies to assess the efficacy and safety of deucrictibant, with positive Phase 2 results bolstering their confidence in its potential.

Through their dedication to research, development, and patient care, Pharvaris is paving the way for advancements in treating angioedema and improving the lives of those who suffer from this challenging condition.

Frequently Asked Questions

What is the focus of the R&D call hosted by Pharvaris?

The R&D call will focus on the novel treatment Deucrictibant and its implications for bradykinin-mediated angioedema.

Who are the presenters for the virtual event?

Presenters include experts from Pharvaris and Amsterdam UMC, specializing in vascular medicine and drug development.

How can interested individuals participate in the event?

Individuals can register for the live webcast through the Pharvaris website under the News and Events section.

What does Pharvaris aim to achieve with Deucrictibant?

Pharvaris aims to provide effective treatment options for patients suffering from HAE and other bradykinin-mediated diseases through Deucrictibant.

Will a recording of the event be available after it concludes?

Yes, an archived replay of the webcast will be available for at least 30 days following the event.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Protecting Teeth: Insights from Endodontist Dr. Joubert

Updated Category News Views 6

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 4

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 4

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 6

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 4

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 9

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 9

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading

Top 5 Most Recently Viewed Articles

Crunch Fitness Expands with New State-of-the-Art Facility

Updated Category News Views 448

Exciting Launch of Crunch Fitness in New Location Crunch Fitness is set to enhance the fitness experience for all in its newest location, a state-of-the-art facility designed to invigorate the community. Positioned at 4701 Colleyville Blvd, this modern gym promises to redefine conventional workout spaces. With elegant lighting and a sleek design,Crunch Colleyville aims to...

Continue Reading
Meketa Capital Unveils New Infrastructure Fund for Advisors

Updated Category News Views 57

Exciting Launch of the Meketa Infrastructure Fund Meketa Capital has made an impactful move by launching the Meketa Infrastructure Fund, which is aimed at registered investment advisors (RIAs). This fund is now accessible through Fidelity’s Institutional Wealth Services and National Financial marketplaces, expanding options for advisors and their clients. Access to a...

Continue Reading
BrightPath Child Care Expands with New School Opening

Updated Category News Views 521

BrightPath Early Learning Opens New Facility in Sugar Grove BrightPath Early Learning and Child Care, a leading provider of early childhood education, proudly announces the opening of its new location in Sugar Grove. This marks a significant milestone as it expands its reach in the Chicago area, adding another option for families seeking high-quality child care services....

Continue Reading
Baltic Horizon Fund Announces SDR Program Termination Plans

Updated Category News Views 133

Baltic Horizon Fund's Termination of SDR Program On February 13, 2025, Baltic Horizon Fund (the Fund) announced the decision to terminate its Swedish Depositary Receipts (SDR) program and subsequently delist from Nasdaq Stockholm. This significant change comes as the Fund aims to streamline its operations and enhance efficiency in the market. Notice of Termination for SDR...

Continue Reading
Cereno Scientific Advances Clinical Trials for PAH Treatment

Updated Category News Views 184

Cereno Scientific Submits Protocol for Phase IIb Trial of CS1 Cereno Scientific, a pioneering biotech, has taken a significant step forward by submitting its Phase IIb trial protocol for CS1 to the U.S. Food and Drug Administration (FDA). This submission marks an important milestone in the company's efforts to enhance healthcare for patients living with pulmonary arterial...

Continue Reading